Hem › Multipel skleros › Tennessee
Kliniska studier för Multipel skleros i Tennessee
6 studier för Multipel skleros söker deltagare vid platser i Tennessee.
Städer i Tennessee
Officiell studietext (engelska)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Hope Neurology, Knoxville
RekryterarFas 2
Ålder 18 till 70 · Alla kön · Uppdaterad 1 okt. 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Clinic PC, Cordova
RekryterarFas 4
Ålder 18 till 65 · Alla kön · Uppdaterad 30 sep. 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Franklin
- TG Therapeutics Investigational Trial Site, Knoxville
- TG Therapeutics Investigational Trial Site, Mount Juliet
- och 2 fler
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Hope Neurology- Site Number : 8400019, Knoxville
RekryterarFas 3
Ålder 18 till 60 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Alliance for Multispecialty Research Clinical, Knoxville
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 15 sep. 2026 · NCT07002034A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology Clinic PC, Cordova
RekryterarFas 3
Ålder 18 till 65 · Alla kön · Uppdaterad 29 juli 2026 · NCT07225504Från ClinicalTrials.gov, data hämtad 2 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.